Search results
3 Generic Drug Stocks to Watch Amid Macro Headwinds
Zacks via Yahoo Finance· 1 year agoThe impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and...
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
Zacks via Yahoo Finance· 1 month agoBausch Health BHC, along with its gastroenterology business, Salix Pharmaceuticals, Inc., announced...
TEVA Beats Q4 Earnings Estimates, Sales Miss & Stock Down
Zacks via Yahoo Finance· 1 year agoTeva Pharmaceutical Industries Limited TEVA reported fourth-quarter 2022 adjusted earnings of 71...
Zacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel...
Zacks via Yahoo Finance· 7 months agoFor Immediate Release Chicago, IL – October 31, 2023 – Today, Zacks Equity Research discusses Dr....
Bausch (BHC) Down on Tentative Approval to Xifaxan ANDA
Zacks via Yahoo Finance· 11 months agoShares of Bausch Health Companies Inc. BHC were down 8.69% on Jun 6 after the FDA granted tentative...
Bausch (BHC) to Appeal Regarding Xifaxan Patent Decision
Zacks via Yahoo Finance· 2 years agoBausch Health Companies Inc. BHC has announced that it will appeal to the U.S. Court of Appeals for...
TEVA Q2 Earnings & Sales Top as Austedo Outperforms, Stock Up
Zacks via Yahoo Finance· 10 months agoTeva Pharmaceutical Industries Limited TEVA reported second-quarter 2023 adjusted earnings of 56...
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product
Benzinga via Yahoo Finance· 1 year agoCatalyst Pharmaceuticals Inc (NASDAQ: CPRX) has received a Notice Letter stating that Teva...